These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22516918)

  • 1. A sensitive and kinetically defined radiochemical assay for canine and human serum thymidine kinase 1 (TK1) to monitor canine malignant lymphoma.
    Sharif H; von Euler H; Westberg S; He E; Wang L; Eriksson S
    Vet J; 2012 Oct; 194(1):40-7. PubMed ID: 22516918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker.
    Jagarlamudi KK; Westberg S; Rönnberg H; Eriksson S
    BMC Vet Res; 2014 Oct; 10():228. PubMed ID: 25293656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management.
    Jagarlamudi KK; Moreau L; Westberg S; Rönnberg H; Eriksson S
    PLoS One; 2015; 10(9):e0137871. PubMed ID: 26366881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum TK1 protein and C-reactive protein correlate to treatment response and predict survival in dogs with hematologic malignancies.
    Saellström S; Sharif H; Jagarlamudi KK; Rönnberg H; Wang L; Eriksson S
    Res Vet Sci; 2022 Jul; 145():213-221. PubMed ID: 35245727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of inactive thymidine kinase 1 polypeptide detected in sera from dogs with solid tumours by immunoaffinity methods: implications for in vitro diagnostics.
    Kiran Kumar J; Sharif H; Westberg S; von Euler H; Eriksson S
    Vet J; 2013 Sep; 197(3):854-60. PubMed ID: 23831216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of serum thymidine kinase 1 in a bacterial infection: canine pyometra.
    Sharif H; Hagman R; Wang L; Eriksson S
    Theriogenology; 2013 Jan; 79(1):17-23. PubMed ID: 23102844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A non-radiometric method for measuring serum thymidine kinase activity in malignant lymphoma in dogs.
    von Euler HP; Ohrvik AB; Eriksson SK
    Res Vet Sci; 2006 Feb; 80(1):17-24. PubMed ID: 16140350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring therapy in canine malignant lymphoma and leukemia with serum thymidine kinase 1 activity--evaluation of a new, fully automated non-radiometric assay.
    Von Euler HP; Rivera P; Aronsson AC; Bengtsson C; Hansson LO; Eriksson SK
    Int J Oncol; 2009 Feb; 34(2):505-10. PubMed ID: 19148486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymidine kinase assay in canine lymphoma.
    Elliott JW; Cripps P; Blackwood L
    Vet Comp Oncol; 2013 Mar; 11(1):1-13. PubMed ID: 22236202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma thymidine kinase activity in dogs with lymphoma and leukemia.
    Nakamura N; Momoi Y; Watari T; Yoshino T; Tsujimoto H; Hasegawa A
    J Vet Med Sci; 1997 Oct; 59(10):957-60. PubMed ID: 9362053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serum thymidine kinase activity in canine splenic hemangiosarcoma*.
    Thamm DH; Kamstock DA; Sharp CR; Johnson SI; Mazzaferro E; Herold LV; Barnes SM; Winkler K; Selting KA
    Vet Comp Oncol; 2012 Dec; 10(4):292-302. PubMed ID: 22236280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytical and clinical characterization of an optimized dual monoclonal sandwich ELISA for the quantification of thymidine kinase 1 (TK1) protein in human blood samples.
    Jagarlamudi KK; L S; M Z; J O; P V; S E
    PLoS One; 2022; 17(10):e0275444. PubMed ID: 36201558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker.
    Jagarlamudi KK; Hansson LO; Eriksson S
    BMC Cancer; 2015 Feb; 15():66. PubMed ID: 25881026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quaternary structures of recombinant, cellular, and serum forms of thymidine kinase 1 from dogs and humans.
    Hanan S; Jagarlamudi KK; Liya W; Ellen H; Staffan E
    BMC Biochem; 2012 Jun; 13():12. PubMed ID: 22741536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal antibody-based sandwich ELISA for measuring canine Thymidine kinase 1 protein and its role as biomarker in canine lymphoma.
    Sharif H; Saellström S; Kolli B; Jagarlamudi KK; Wang L; Rönnberg H; Eriksson S
    Front Vet Sci; 2023; 10():1243853. PubMed ID: 37808109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of equine thymidine kinase 1 and preliminary evaluation of its suitability as a serum biomarker for equine lymphoma.
    Wang L; Unger L; Sharif H; Eriksson S; Gerber V; Rönnberg H
    BMC Mol Cell Biol; 2021 Dec; 22(1):59. PubMed ID: 34906077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum thymidine kinase 1 protein concentrations and presence of its autoantibody as biomarkers for screening dogs with malignant tumors.
    Kim Y; Park J; Kim B; Yu KR; Kim HS; Oh Y; Seo K; Ryu M; Park C; Bhang D; Choi U; Youn H
    J Vet Intern Med; 2024; 38(1):300-307. PubMed ID: 38088206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymidine kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker.
    Jagarlamudi KK; Shaw M
    Biomark Med; 2018 Sep; 12(9):1035-1048. PubMed ID: 30039979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum thymidine kinase activity in dogs with malignant lymphoma: a potent marker for prognosis and monitoring the disease.
    von Euler H; Einarsson R; Olsson U; Lagerstedt AS; Eriksson S
    J Vet Intern Med; 2004; 18(5):696-702. PubMed ID: 15515587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical evaluation of the TK 210 ELISA in sera from breast cancer patients demonstrates high sensitivity and specificity in all stages of disease.
    Kumar JK; Aronsson AC; Pilko G; Zupan M; Kumer K; Fabjan T; Osredkar J; Eriksson S
    Tumour Biol; 2016 Sep; 37(9):11937-11945. PubMed ID: 27079872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.